Universidade do Vale do Sapucai

Quick facts

Phase 3 pipeline

• Group Hydroxychloroquine and apixaban · Immunology / Rheumatology / Cardiovascular
  This combination pairs hydroxychloroquine, an immunomodulator that reduces inflammation and autoimmune activity, with apixaban, an anticoagulant that inhibits Factor Xa to prevent thrombosis.

Phase 2 pipeline

• Medicinal Plant

Phase 1 pipeline

• Acmella oleracea gel
• Alpha bisabolol gel
• Alpha bisabolol product
• CSAAC
• CSAC
• Gel with 10% peel powder of unripe banana
• Lepidium Meyenii Walp
• Lidocaine 2 % Topical Cream

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Universidade do Vale do Sapucai portfolio CI brief
• Universidade do Vale do Sapucai pipeline updates RSS